期刊文献+

siRNA介导的RNAi降低了CD59对补体溶破的抵抗作用 被引量:8

Knocking down human CD59 gene expression decreased protection to complement-mediated cytolysis
在线阅读 下载PDF
导出
摘要 目的:构建针对人CD59基因的siRNA表达载体并筛选稳定细胞系,观察CD59基因改变后对补体溶破的抵抗作用的变化,探讨CD59在肿瘤细胞免疫逃逸及相关信号转导通路中的作用。方法:应用siRNA表达载体介导的RNAi技术,构建含特异性CD59基因的重组载体,脂质体法转染A2780细胞,G418筛选建立稳定抑制的细胞克隆,RT-PCR和Western blot检测转染细胞中CD59基因的表达抑制效果,染料释放试验判断CD59基因抑制后对补体溶破的抵抗作用的影响。结果:重组载体经PCR及限制性内切酶酶切鉴定初步成功后送测序,结果表明序列正确;重组载体转染A2780细胞,可表达绿色荧光蛋白,经G418筛选,得到抗性细胞克隆,RT-PCR和Western blot表明,稳定转染后CD59基因的mRNA和蛋白水平降低,染料释放试验表明CD59基因受抑制后对补体溶破的抵抗作用降低。结论:特异性沉默CD59基因的siRNA表达载体以及稳定抑制的细胞系构建和筛选成功,CD59基因抑制后对补体溶破的抵抗作用降低,为后续进行肿瘤细胞的研究奠定了基础。 AIM: To construct recombinant vectors expressing siRNA that target CD59 gene and a stable-inhibit cell line A2780 in order to analyze the role of CD59 in the protection to complement-mediated cytolysis. METHODS: The 60 bp encoded targeting CD59 gene shRNA sequence was cloned into pSUPER vector with DNA recombinant technique. The ovary cancer cell A2780 was transfected with this recombinant plasmid using liposome and the stable strains was selected by using G418-medium, CD59 mRNA and pro- tein level was detected by RT-PCR and Western blot, and its function was analysed by dye release assay. RESULTS: The pSUPER-siRNA expressing vector was successfully constructed. And a stable cell line A2780 was selected and was detected the expression of GFP. The siRNA vector effectively inhibited the CD59 gene expression from mRNA and protein level. Dye release assay suggested that CD59's protection to complement-mediated cytolysis decreased. CONCLUSION: The siRNA vector targeting CD59 gene could consistently inhibit CD59 expression. Furthermore, it decreased CD59's protection against complement. These results may pave the way for studying the role of CD59 in the immune escape of tumors cells as well as in tumor therapy.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2008年第12期1164-1166,1173,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 国家自然科学基金资助项目(30671936)
关键词 SHRNA CD59 A2780 补体 shRNA CD59 A2780 complement
作者简介 石学香(1975-),女,山东青岛人,主管医师,博士生;Tel:0532-83780021;E-mail:talkxyz@163.com Corresponding author:高美华 E-mail:meihuagao2007@126.com
  • 相关文献

参考文献1

二级参考文献10

  • 1Zhao J,Rollins SA,Maher SE,Bothwell AL,Sims PJ.Amplified gene expression in CD59-transfected Chinese hamster ovary cells confers protection against the membrane attack complex of human complement[].Journal of Biological Chemistry.1991
  • 2Halperin JA,Taratuska A,Rynkiewicz M,Nicholson-Weller A.Transient changes in erythrocyte membrane permeability are induced by sublytic amounts of the complement membrane attack complex(C5b-9)[].Blood.1993
  • 3Fletcher CM,Harrison RA,Lachmann PJ,Neuhaus D.Sequence-specific 1H-NMR assignments and folding topology of human CD59[].Protein Science.1993
  • 4Ferriani VPL,Harrison RA,Lachman PJL.C5b-9 binds to N-terminal portion of CD59[].Molecular Immunology.1993
  • 5Bodian DL,Davis SJ,Morgan BP,Rushmere NK.Mutational analysis of the active site and antibody epitopes of the complement-inhibitory glycoprotein,CD59[].The Journal of Experimental Medicine.1997
  • 6Ninomiya H,Stewart BH,Rollins SA,Zhao J,Bothwell AL,Sims PJ.Contribution of the N-linked carbohydrate of erythrocyte antigen CD59 to its complement-inhibitory activity[].Journal of Biological Chemistry.1992
  • 7Brownlee M,Vlassara H,Cerami A.Nonenzymatic glycosylation and the pathogenesis of diabetic complications[].Annals of Internal Medicine.1984
  • 8Hüsler T,Lockert DH,Kaufman KM,Sodetz JM,Sims PJ.Chimeras of human complement C9 reveal the site recognized by complement regulatory protein CD59[].Journal of Biological Chemistry.1995
  • 9Sims PJ,Faioni EM,Wiedmer T,Shattil SJ.Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity[].Journal of Biological Chemistry.1988
  • 10Brooimans RA,van Wieringen PA,van Es LA,Daha MR.Relative roles of decay-accelerating factor,membrane cofactor prtotein,and CD59 in the protection of human endothelial cells against complement-mediated lysis[].European Journal of Immunology.1992

共引文献2

同被引文献73

  • 1解西河,高美华.前列腺细胞高表达的CD59分子活性位点的封闭研究[J].免疫学杂志,2009,25(1):68-70. 被引量:1
  • 2GONG YuanYing1,2, PENG MinSheng1,2, ZHOU WeiPing1,3,4 & ZHANG YaPing1,4 1 State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming 650223, China,2 Graduate University of the Chinese Academy of Sciences, Beijing 100049, China,3 Molecular and Cell Biology, University of Science and Technology of China, Hefei 230026, China,4 Laboratory for Conservation and Utilization of Bio-resources, Yunnan University, Kunming 650091, China.Evolution of cd59 gene in mammals[J].Science China(Life Sciences),2007,50(6):773-779. 被引量:1
  • 3朱有凯,林汉良,顾霞,张萌,吴红阳,许湘.shRNA干扰Jurkat细胞株MDM2表达对细胞生物特性的影响[J].临床与实验病理学杂志,2005,21(3):347-350. 被引量:3
  • 4程颖,高美华.利用噬菌体肽库筛选与人CD59特异性结合的短肽[J].细胞与分子免疫学杂志,2006,22(2):164-166. 被引量:10
  • 5秦诚,蔡小勇.补体调节蛋白CD46、CD55及CD59在肿瘤免疫治疗中的研究进展[J].癌症,2006,25(11):1450-1453. 被引量:19
  • 6Kimberley F C, Sivasankar B, Paul Morgan B. Alternative roles for CD59 [J]. Mol Immunol,2007;44(1-3) :73-81.
  • 7Babiker A A, Nilsson B, Ronquist G et al. Transfer of functional prostasomal CD59 of metastatic prostatic cancer cell origin protects cells against complement attack [ J ]. Prostate, 2005 ; 62 (2) : 105-114.
  • 8Bjφrge L, Hakulinen J, Wahlstrom T et al. Complement-regulatory proteins in ovarian malignancies[J], hat J Cancer, 1997;70( 1 ) : 14-25.
  • 9Fonsatti E, Altomonte M, Coral Set al. Emerging role of protectin (CD59) in humoral immunotherapy of solid malignancies [ J ]. Clin Ter, 2000; 151 (3) : 187-193.
  • 10Iborra A, Mayorga M, Llobet N et al. Expression of complement regulatory proteins [ membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin ( CD59 ) ] in endometrial stressed cells [ J ]. Cell Immunol, 2003 ; 223 ( 1 ) : 46-51.

引证文献8

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部